[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"iliac-nodal-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:iliac-nodal-disease":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100579956","elective-adaptive-radiation-with-sbrt-for-improved-durability-of-response-100579956",false,"NCT06831032","Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response","A Phase I, Prospective, Single-Arm Feasibility Study: Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response (EASY)","EASY","Inclusion Criteria:\n\n1. Histologically confirmed prostate adenocarcinoma.\n2. Oligorecurrent para-aortic +\u002F- common iliac nodal disease planned for SBRT.\n3. ≤10 involved para-aortic (defined as between L1\u002FL2 interface and L4\u002FL5 interface) +\u002F- common iliac LN on PSMA PET imaging.\n4. ECOG performance status 0-2.\n\nExclusion Criteria:\n\n1. Prior radiotherapy to the nodal echelon (PA +\u002F- common iliac).\n2. Active secondary malignancy, except for adequately treated non-melanoma skin cancer.\n3. Presence of significant comorbidities or medical conditions that may compromise the ability to undergo radiotherapy or participate in the study.\n4. Contraindication to radiation.","MALE","18 Years",{"count":20,"type":21},26,"ESTIMATED","INTERVENTIONAL",[24],"NA","This prospective, single-arm feasibility study will include patients with prostate cancer that have controlled local disease diagnosed with oligorecurrent para-aortic nodal disease and\u002For common iliac nodal disease detected by PSMA PET or conventional CT\u002FMRI imaging, and these patients will undergo CT-guided online adaptive SBRT to the tumor and elective SBRT to adjacent at-risk nodal regions.",[27,28,29,30,31],"Prostate Adenocarcinoma","Iliac Nodal Disease","Para-aortic Lymph Node Metastasis","Para-aortic Nodal Disease","Oligorecurrence","RECRUITING","2026-03-18",{"date":35,"type":36},"2026-03-23","ACTUAL",{"date":38,"type":21},"2026-07-07",{"date":40,"type":21},"2029-07-07",{"name":42,"class":43},"University Health Network, Toronto","OTHER"]